| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/24/24 | 8-K | Current report filing |
|
   |
11 |
| 01/24/24 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
20 | |
| 01/18/24 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
34 | |
| 01/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
38 |
| 01/04/24 | 8-K | Current report filing |
|
|
8 |
| 12/08/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/08/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
15 | |
| 12/06/23 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 12/06/23 | UPLOAD | SEC-generated letter |
|
1 | |
| 11/30/23 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
25 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.